Hemophagocytic lymphohistiocytosis in critically ill patients: A guide for clinicians. [PDF]
Nedel W.
europepmc +1 more source
Breaking the storm: canakinumab as salvage therapy for refractory macrophage activation syndrome in pediatric systemic lupus erythematosus-a case report. [PDF]
Selvarajan T +4 more
europepmc +1 more source
Long-term anakinra therapy in Schnitzler syndrome: real-world evidence on remission of neutrophilic dermatitis and systemic inflammation, safety, biomarker insights and dose optimization. [PDF]
Sikora M +3 more
europepmc +1 more source
Case Report: Acute Sarcoid Myositis Mimicking Protracted Febrile Myalgia in Familial Mediterranean Fever. [PDF]
Ata EB +4 more
europepmc +1 more source
Macrophage activation syndrome in systemic lupus erythematous and Still's disease: distinct phenotypes shaped by the underlying diseases. [PDF]
Tonutti A +26 more
europepmc +1 more source
Hepatobiliary involvement in Kawasaki disease: from cholestatic hepatitis to the hepatic vascular-biliary unit hypothesis-a state-of-the-art review. [PDF]
Zhong YX, Zheng Q, Yang FY.
europepmc +1 more source
Early steroid and anakinra use to manage axicabtagene ciloleucel toxicity reduces the total duration of CRS and ICANS. [PDF]
Wang WL +22 more
europepmc +1 more source
Anakinra for the Treatment of Hemophagocytic Lymphohistiocytosis: 21 Cases
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening cytokine storm syndrome. There are no definitive guidelines for the management of secondary HLH (sHLH).
Yvan Jamilloux +2 more
exaly +2 more sources

